High-Grade Progression, Sarcomatous Transformation, and/or Metastasis of Pituitary Neuroendocrine Neoplasms (PitNENs): The UCSF Experience.

Autor: Terry M; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA., Nguyen MP; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA., Tang V; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA., Guney E; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA., Bharani KL; Department of Pathology, Stanford University, Palo Alto, CA, USA., Dahiya S; Department of Pathology, Washington University, St. Louis, MO, USA., Choutka O; Department of Neurosurgery, Saint Alphonsus Neuroscience Institute, Boise, ID, USA., Borys E; Department of Pathology, Loyola University, Chicago, IL, USA., Reis G; Department of Pathology, Memorial Healthcare System, Hollywood, FL, USA., Blevins L; Department of Endocrinology, University of California San Francisco, San Francisco, CA, USA., Aghi MK; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Kunwar S; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., DeGroot J; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA., Raleigh DR; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA., Pekmezci M; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA., Bollen AW; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA., Cha S; Department of Radiology, University of California San Francisco, San Francisco, CA, USA., Joseph NM; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA., Perry A; Department of Pathology, Division of Neuropathology, University of California San Francisco, San Francisco, CA, USA. arie.perry@ucsf.edu.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. arie.perry@ucsf.edu.

Publikováno v: Endocrine pathology [Endocr Pathol] 2024 Dec; Vol. 35 (4), pp. 338-348. Date of Electronic Publication: 2024 Oct 10.

Generation of Bayesian prediction models for OATP-mediated drug–drug interactions based on inhibition screen of OATP1B1, OATP1B1∗15 and OATP1B3

Autor: van de Steeg, E., Venhorst, J., Jansen, H.T., Nooijen, I.H.G., DeGroot, J., Wortelboer, H.M., Vlaming, M.L.H.

Publikováno v: In European Journal of Pharmaceutical Sciences 5 April 2015 70:29-36

Skin pentosidine in very early hip/knee osteoarthritis (CHECK) is not a strong independent predictor of radiographic progression over 5 years follow-up

Autor: Vos, P.A.J.M. ^{†, ‡}, Welsing, P.M.J. ^{†, §}, deGroot, J. ^∥, Huisman, A.M. ^¶, Oostveen, J.C.M. ^#, Reijman, M. ^††, Damen, J. ^‡‡, Mastbergen, S.C. ^†, Lafeber, F.P.J.G. ^†

Publikováno v: In Osteoarthritis and Cartilage June 2013 21(6):823-830

In end stage osteoarthritis, cartilage tissue pentosidine levels are inversely related to parameters of cartilage damage

Autor: Vos, P.A.J.M. ^{†, ‡}, Mastbergen, S.C. ^†, Huisman, A.M. ^§, de Boer, T.N. ^†, DeGroot, J. ^‖, Polak, A.A. ^¶, Lafeber, F.P.J.G. ^†

Publikováno v: In Osteoarthritis and Cartilage March 2012 20(3):233-240

Skin and urine pentosidine weakly correlate with joint damage in a cohort of patients with early signs of osteoarthritis (CHECK)

Autor: Vos, P.A.J.M. ^†, DeGroot, J. ^‡, Huisman, A.M. ^§, Oostveen, J.C.M. ^∥, Marijnissen, A.C.A. ^¶, Bijlsma, J.W.J. ^¶, van El, B. ^‡, Zuurmond, A.M. ^‡, Lafeber, F.P.J.G. ^{¶, ∗}

Publikováno v: In Osteoarthritis and Cartilage 2010 18(10):1329-1336